1 | ALN-CC5 | - | - | - | - | [4] 11 11, 62, 66, 109 |
2 | Apremilast (CC-10004) | [1] Apremilast Apremilast | [1] D08860
D08860
| [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 56 56 |
3 | Behavioral: Collaborative Care (CC) | - | - | - | - | [1] 13 13 |
4 | Candesartan plus non-CCB agents | [1] Candesartan Candesartan | [1] D00522
D00522
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 67 67 |
5 | CC | - | - | - | - | [14] 13 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271 |
6 | CC-100004 | - | - | - | - | [1] 84 84 |
7 | CC-10004 | - | - | - | - | [5] 46 46, 56, 97, 162, 271 |
8 | CC-220 | [1] CC-220 CC-220 | - | - | - | [2] 49 49, 84 |
9 | CC-220 0.3 mg Daily | [1] CC-220 CC-220 | - | - | - | [1] 84 84 |
10 | CC-220 0.6mg Daily | [1] CC-220 CC-220 | - | - | - | [1] 84 84 |
11 | CC-292 | - | - | - | - | [1] 46 46 |
12 | CC-4047 | - | - | - | - | [2] 28 28, 51 |
13 | CC-5013 | - | - | - | - | [2] 28 28, 96 |
14 | CC-90001 | - | - | - | - | [1] 85 85 |
15 | CC-930 | - | - | - | - | [1] 85 85 |
16 | CC-93538 | - | - | - | - | [1] 98 98 |
17 | CC-99677 | - | - | - | - | [1] 271 271 |
18 | CC-99677 30mg Capsule | - | - | - | - | [1] 271 271 |
19 | CC-99677 60mg Capsule | - | - | - | - | [1] 271 271 |
20 | CC100 | - | - | - | - | [1] 2 2 |
21 | CCD 1042 | - | - | - | - | [1] 152 152 |
22 | CCD 1042, MD 9150000, Mepalon 1042, SPT316 | - | - | - | - | [2] 152 152, 206 |
23 | CCD 1042, MD 9150000, Mepalon 1042, SPT3162 | - | - | - | - | [1] 152 152 |
24 | CCI-779 | - | - | - | - | [2] 13 13, 46 |
25 | CCP-020 | - | - | - | - | [1] 36 36 |
26 | CCP-690-550-10 | - | - | - | - | [1] 107 107 |
27 | CCR1 Antagonist | - | - | - | - | [1] 46 46 |
28 | CCX 354 | - | - | - | - | [1] 46 46 |
29 | CCX 354-C | - | - | - | - | [1] 46 46 |
30 | CCX-354 | [1] CCX-354 CCX-354 | - | - | - | [1] 46 46 |
31 | CCX-354-C | [1] CCX-354 CCX-354 | - | - | - | [1] 46 46 |
32 | CCX140 | - | - | - | - | [1] 222 222 |
33 | CCX140-B | - | - | - | - | [1] 222 222 |
34 | CCX168 | - | - | - | - | [5] 43 43, 44, 66, 109, 222 |
35 | CCX282-B | - | - | - | - | [1] 96 96 |
36 | CCX354 | - | - | - | - | [1] 46 46 |
37 | CCX354-C | - | - | - | - | [1] 46 46 |
38 | DTR Melatonin (NIH CC PDS) | [1] Melatonin Melatonin | [1] D08170
D08170
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 202 202 |
39 | Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one) | [1] Ganaxolone Ganaxolone | [1] D04300
D04300
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 152 152 |
40 | Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one) | [1] Ganaxolone Ganaxolone | [1] D04300
D04300
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 152 152 |
41 | OPL-CCL2-LPM | - | - | - | - | [1] 66 66 |
42 | Pomalidomide (CC-4047 | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 |
43 | Pomalidomide (CC-4047) | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 |